Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.
📍 The outcome
A new blood test called Stockholm3 was found to detect more high-risk prostate cancer cases than PSA tests. This multicomponent test outperformed PSA for detecting clinically significant cancers and could improve screening when used with MRI.
Epilogue added 33d ago, after coverage quieted.
Quick answers
What is the name of the new blood test?
The test is referred to as Stockholm3 in coverage from 2 Minute Medicine.
How does it compare to the PSA test?
The test is reported to outperform the PSA for detecting significant prostate cancer, with The Telegraph stating it detects twice as many cases.
Can this test be used with other diagnostic tools?
According to AuntMinnie, blood-based testing could improve screening when used with MRI.
The brief
A new blood test, identified in coverage as Stockholm3, is demonstrating a higher detection rate for high-risk and clinically significant prostate cancer cases. According to The Telegraph, the test detects twice as many cases as previous methods.
Reporting from MedPage Today, 2 Minute Medicine, and Medical Xpress emphasizes that this multicomponent test tops the traditional PSA (Prostate-Specific Antigen) test in performance. AuntMinnie notes that blood-based testing could further improve screening when used in conjunction with MRI.
Coverage focuses on the test's ability to identify high-risk cases more effectively than the PSA. Future developments involve the integration of these blood tests with imaging technologies like MRI to enhance screening outcomes.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Who reported it (5)
- Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers MedPage Today · 47d ago
- Blood-based testing could improve prostate cancer screening with MRI AuntMinnie · 47d ago
- Stockholm3 outperforms PSA for detecting significant prostate cancer 2 Minute Medicine · 47d ago
- New blood test detects more high-risk prostate cancer cases Medical Xpress · 47d ago
- Prostate cancer blood test detects twice as many cases The Telegraph · 47d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
CRISPR makes prostate cancer vulnerable to immunotherapy
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
From doctor to patient: Retired radiologist undergoes robotic surgery for prostate cancer
Medical experts are highlighting the critical role of early detection and robotic surgery as prostate cancer cases rise beyond metropolitan areas.
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second PSMA PET scan may alter the treatment course for nearly 50% of prostate cancer patients, according to new study data.
'Endometriosis tests would have given me years back'
New diagnostic testing methods using saliva and blood analysis are emerging as potential alternatives for identifying endometriosis.
Is testosterone replacement a fix for the blahs of aging?
A shift in government policy regarding testosterone therapy is sparking a debate over the treatment of age-related hormone decline.